ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Rimteravimab Biosimilar - Anti-SARS-CoV-2 Spike Protein RBD Antibody - BSA and Azide free (A339186)

Recombinant chimeric monoclonal antibody to SARS-CoV-2 Spike Protein RBD for use as a research grade Rimteravimab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.

Shipping Information

$40
Dispatched from St. Louis, MO.
Lead Time: 7-10 business days.
Name
Rimteravimab Biosimilar - Anti-SARS-CoV-2 Spike Protein RBD Antibody - BSA and Azide free
Description
Recombinant chimeric monoclonal antibody to SARS-CoV-2 Spike Protein RBD for use as a research grade Rimteravimab biosimilar.
Applications
ELISA, Flow Cytometry, Functional Studies, in vivo Research
Reactivity
SARS-CoV-2 (2019-nCoV)
Host
Chimeric
Clonality
Monoclonal
Conjugate

Unconjugated

Purity
The purity of this Biosimilar is >95%, as determined by SDS-PAGE.
Product Form
Liquid
Formulation
Supplied in 0.01M Phosphate Buffered Saline, pH 7.4.
Storage
Shipped at 4°C. Upon delivery store at 4°C for short-term use (1-2 weeks) or aliquot and store at -20°C for long-term use (up to 12 months).
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Rimteravimab Biosimilar - Anti-SARS-CoV-2 Spike Protein RBD Antibody - BSA and Azide free (A339186)? Please let us know so that we can list the citation on this page.